Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

8.3%

1 terminated/withdrawn out of 12 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

17%

2 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

5(71.4%)

Phase 4

2(28.6%)

7Total

N/A(5)

Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)

Showing 12 of 12 trials

NCT06347393Not ApplicableActive Not Recruiting

Transgender and Gender Diverse Individuals Screening for Breast Cancer

Role: collaborator

NCT02311192Not ApplicableWithdrawn

Grading Scale of Vitreous Haze in Patients With Uveitis Using Ultrasonography

Role: collaborator

NCT04463849Not ApplicableCompleted

Effects of COVID-19 Infection on Beta-cell Function in Euglycemic Patients

Role: collaborator

NCT05528029Unknown

International Ledless Pacemaker Registry

Role: lead

NCT05636046Unknown

Transseptal Italian Registry (TITLE)

Role: lead

NCT04373876Unknown

Experience From the Italian S-ICD Registry

Role: lead

NCT04544397Unknown

Outcomes of Second Generation Laser Balloon Ablation for Atrial Fibrillation

Role: lead

NCT03553381Completed

Oxidative Stress, Inflammation, and Lipoprotein in Metabolic Syndrome

Role: collaborator

NCT03365700Not ApplicableUnknown

Cryoballon Versus Radiofrequency Ablation for Persistent Atrial Fibrillation

Role: lead

NCT02248337Phase 4Completed

Low Volume Colon Preparation for IBD

Role: lead

NCT01928654Not ApplicableUnknown

Comparison Between Treatment With Yellow Micropulse Laser and Green Conventional Laser in Diabetic Macular Edema

Role: lead

NCT01909219Phase 4Completed

PMC Split Preparation for Colon Cleansing

Role: lead

All 12 trials loaded